Researchers Leverage ‘Junk DNA’ to Target Hard-to-Treat Blood Cancers
London: Researchers at King’s College London have uncovered a novel strategy for treating certain aggressive blood cancers by targeting a once-overlooked part of the genome-so-called ‘junk DNA’-using existing cancer drugs.